However, our results do provide a framework to extend these analyses to other cellular and physiological settings considering the context of TP53 family members mutational status, isoform expression and post-translational modifications to better determine how this network is de-regulated in cancer (reviewed in (74,75)). This evidence concerns the gene TP53 and cancer.